论文信息 - Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine - 字舞流文

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine

H. Frijlink | E. Hak | E. van Doorn | Heng Liu | S. Norley | T. Ben-Yedidia | I. Visontai | S. Hassin | Eva van Doorn